Iovance CRO has 9,766 RSUs vest into shares
IOVA’s Chief Regulatory Officer reports RSU vesting with shares withheld for taxes, not sold on the open market.
Rhea-AI Filing Summary
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported that Chief Regulatory Officer Raj K. Puri had restricted stock units vest on September 8, 2026, converting 9,766 RSUs into an equal number of common shares. Of these, 4,478 shares were withheld by the company at $8.70 per share to satisfy mandatory tax withholding requirements, which the company notes was not an open-market sale. Following the RSU exercise, 58,599 RSUs from the March 5, 2025 grant remain outstanding and will vest in equal quarterly installments, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F4, F5, F6 | 9,766 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 9,766 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F2, F3 | 4,478 | $8.70 | $39K |
Footnotes (6)
- F1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- F2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- F3. Represents the common stock remaining after deducting the common stock withheld for taxes.
- F4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5. The remaining RSUs will vest in equal quarterly installments.
- F6. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.
Key Figures
Key Terms
Restricted Stock Units financial
mandatory tax withholding requirements financial
contingent right financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IOVA report for Chief Regulatory Officer Raj K. Puri?
How many IOVA restricted stock units does Raj K. Puri still hold from the March 5, 2025 grant?
What is the vesting schedule for Raj K. Puri’s remaining IOVA RSUs?
Was a Rule 10b5-1 trading plan involved in the IOVA Form 4 transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.